Related Experiment Videos
[Corticosteroid for fetal lung maturation: indication and treatment protocols]
1Service de Gynécologie-Obstétrique, CHI Poissy-Saint-Germain, 10, rue du Champ-Gaillard, 78300 Poissy.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|November 28, 2002
Summary
A single course of antenatal corticosteroids significantly reduces complications in premature infants, including mortality and respiratory distress syndrome. Betamethasone is preferred for its proven benefits in reducing neonatal mortality and periventricular leukomalacia.
Area of Science:
- Obstetrics and Neonatal Medicine
- Pharmacology
- Clinical Trial Analysis
Context:
- Antenatal corticosteroid therapy is a cornerstone in managing preterm birth risks.
- Crowley's analysis synthesized data from fifteen randomized controlled trials.
Purpose:
- To evaluate the efficacy and safety of antenatal corticosteroid courses for preventing prematurity-related complications.
- To compare single versus repeated courses of steroids and different steroid agents.
Summary:
- A single course of antenatal steroids demonstrably reduces neonatal mortality, respiratory distress syndrome, intraventricular hemorrhage, and necrotizing enterocolitis.
- Betamethasone is recommended over dexamethasone due to its proven efficacy in reducing neonatal mortality and periventricular leukomalacia.
- While repeated steroid courses may improve lung function in very preterm infants (before 28 weeks), concerns exist regarding adverse effects like reduced birth weight and head circumference, though long-term follow-up shows similar outcomes to single courses.
Impact:
- Confirms the indisputable benefit of a single course of antenatal steroids for preventing major complications of preterm birth.
- Highlights ongoing concerns regarding the benefit-risk ratio of repeated antenatal corticosteroid courses.
- Provides evidence-based guidance on the preferred choice of steroid (betamethasone) for antenatal therapy.